Keyphrases
Respiratory Syncytial Virus
100%
Young children
100%
Respiratory Syncytial Virus Hospitalization
100%
Denmark
100%
Hospitalization
57%
Young Infants
28%
Age-specific Incidence
14%
5-year-old
14%
High Risk
14%
Microbiology
14%
Respiratory Syncytial Virus Infection
14%
Male-to-female Ratio
14%
Western Countries
14%
Protective Immune Response
14%
Future Decisions
14%
National Registry Data
14%
Vaccination Strategy
14%
National Immunization Program
14%
Children's Health
14%
Vital Statistics
14%
Direct Medical Costs
14%
High Incidence
14%
Increasing Age
14%
Medicine and Dentistry
Human respiratory syncytial virus
100%
Seasonal Variation
100%
Toddlers
100%
Health Care Cost
25%
Immune Response
12%
Vital Statistic
12%
Respiratory Syncytial Virus Infection
12%
Nursing and Health Professions
Vital Statistic
100%
Respiratory Syncytial Virus Infection
100%
Pharmacology, Toxicology and Pharmaceutical Science
Human respiratory syncytial virus
100%
Vital Statistic
12%
Respiratory Syncytial Virus Infection
12%
Agricultural and Biological Sciences
Human respiratory syncytial virus
100%
Biochemistry, Genetics and Molecular Biology